CD8A and neoplasm: It has been demonstrated that human TLR8 signaling can reverse the suppressive functions of naturally occurring Treg cells and tumor-derived CD4+, CD8+, and γδ Treg cells, which resulted in enhanced anti-tumor immunity (18).